Christina K. Isacson Ph.D.

Christina Isacson is a Partner at Lightstone Ventures focusing on early-stage biopharmaceutical investments. With a Ph. D. in Neuroscience from Tufts University, she has over 20 years of experience launching and operating biotech companies, including serving on the founding teams of Magenta Therapeutics and Decibel Therapeutics.

She is a vocal advocate for advancing research and investment in womens health, partnering with organizations like Womens Health Access Matters (WHAM). She champions a data-driven approach to close the gender gap in healthcare, arguing that focusing on women as a pivotal patient population maximizes market opportunity and returns.

She believes high-growth opportunities exist in autoimmune, neurology, and cardio-metabolic diseases where data shows women are disproportionately affected.